CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Tenax Therapeutics Inc Company Snapshot
Tenax Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tenax Therapeutics Inc with three other companies in this sector in the United States: Cormedix Incorporation (2014 sales of $189,274.00 of which 100% was Medical Service), Revance Therapeutics Inc ($383,000.00 of which 100% was Botulinum Toxin Products), and Cure Pharmaceutical Holding Corp ($251,832.00 ).

Sales Analysis.
   
   
 
  Stock Performance Chart for Tenax Therapeutics Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): .36
(Figures in U.S. Dollars)
1 Week -13.0%   13 Weeks -27.0%  
4 Weeks -20.7%   52 Weeks -85.4%  
 
Tenax Therapeutics Inc Key Data:
  Ticker: TENX Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2014 Sales 288,726
(Year Ending Jan 2015).
Employees: 11
  Currency: U.S. Dollars Market Cap: 10,300,692
  Fiscal Yr Ends: December Shares Outstanding: 28,236,546
  Share Type: Common Closely Held Shares: 4,933,378
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.